Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-25-046256
Filing Date
2025-10-24
Accepted
2025-10-24 16:01:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 contexttherapeutics424b5oc.htm 424B5 384689
2 contexttherapeuticsimage.jpg GRAPHIC 32139
  Complete submission text file 0001628280-25-046256.txt   430189
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283037 | Film No.: 251416127
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)